FDA recall D-0724-2021

Noven Pharmaceuticals Inc · Class II · drug

Product

Combipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.14 mg per day, 50/140 Twice Weekly, Rx Only a) 2 Systems NDC 68968-0514-2 b) 8 Systems NDC 68968-0514-8, Mfd. by: Noven Pharmaceuticals, Inc., Miami, Florida 33186, Dist. by: Noven Therapeutics LLC, Miami, Florida 33186

Reason for recall

Failed Stability Specifications; out of specification for shear.

Distribution

Nationwide.

Key facts

Status
Ongoing
Initiation date
2021-07-30
Report date
2021-08-25
Voluntary/Mandated
Voluntary: Firm initiated
Location
Miami, FL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0724-2021